Pharmaceutical care for patients with breast and ovarian cancer

Supportive Care in Cancer

Volumn 20, Issue 11, 2012, Pages 2669-2677

  Liekweg, Andrea ^a   Westfeld, Martina ^a   Braun, Michael ^a   Zivanovic, Oliver ^a   Schink, Tania ^b   Kuhn, Walther ^a   Jaehde, Ulrich ^a  

^a UNIVERSITY OF BONN   (Germany)

^b LEIBNIZ INSTITUTE FOR PREVENTION RESEARCH AND EPIDEMIOLOGY BIPS   (Germany)

Author keywords

Breast cancer; Patient reported outcomes; Pharmaceutical care; Quality of life; Supportive Care; Toxicity

Indexed keywords

ANTIEMETIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; PACLITAXEL;

ADULT; ANOREXIA; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; COHORT ANALYSIS; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; FATIGUE; FEASIBILITY STUDY; FEMALE; HUMAN; INSOMNIA; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA; OUTCOME ASSESSMENT; OVARY CANCER; PAIN; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; TREATMENT OUTCOME;

ADULT; AGED; ANTIEMETICS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COHORT STUDIES; FEASIBILITY STUDIES; FEMALE; HUMANS; MIDDLE AGED; NAUSEA; OUTCOME ASSESSMENT (HEALTH CARE); OVARIAN NEOPLASMS; PATIENT EDUCATION AS TOPIC; PATIENT SATISFACTION; PHARMACEUTICAL SERVICES; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; VOMITING;

EID: 84868509089     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-012-1385-z     Document Type: Article

References (35)

1. Feyer P, Kleeberg UR, Steingraber M, Gunther W, Behrens M (2008) Frequency of side effects in outpatient cancer care and their influence on patient satisfaction - a prospective survey using the PASQOC questionnaire. Support Care Cancer 16:567-575
2. Sun CC, Bodurka DC, Weaver CB, Rasu R, Wolf JK, Bevers MW, Smith JA, Wharton JT, Rubinstein EB (2005) Rankings and symptom assessment of side effects from chemotherapy: insights from experienced patients with ovarian cancer. Support Care Cancer 13:219-227
3. Mertens WC, Higby DJ, Brown D, Parisi R, Fitzgerald J, Benjamin EM, Lindenauer PK (2003) Improving the care of patients with regard to chemotherapy-induced nausea and emesis: the effect of feedback to clinicians on adherence to antiemetic prescribing guidelines. J Clin Oncol 21:1373-1378
4. Norton PG, Baker GR (2007) Patient safety in cancer care: a time for action. J Natl Cancer Inst 99:579-580
5. Weingart SN, Cleary A, Seger A, Eng TK, Saadeh M, Gross A, Shulman LN (2007) Medication reconciliation in ambulatory oncology. Jt Comm J Qual Patient Saf 33:750-757
6. Hepler CD, Strand LM (1990) Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 47:533-543
7. Schwartz RN, Eng KJ, Frieze DA, Gosselin TK, Griffith N, Seung AH, Hinkel JM, Johnson PE, Johnson SA, Li EC, Szabatura AH, Wong MK (2010) NCCN Task Force Report: Specialty Pharmacy. J Natl Compr Canc Netw 8(Suppl 4):S1-S12
8. Liekweg A, Westfeld M, Jaehde U (2004) From oncology pharmacy to pharmaceutical care: new contributions to multidisciplinary cancer care. Support Care Cancer 12:73-79
9. Skalla KA, Bakitas M, Furstenberg CT, Ahles T, Henderson JV (2004) Patients' need for information about cancer therapy. Oncol Nurs Forum 31:313-319
10. Elf M,Wikblad K (2001) Satisfaction with information and quality of life in patients undergoing chemotherapy for cancer. The role of individual differences in information preference. Cancer Nurs 24:351-356
11. Garcia SF, Cella D, Clauser SB, Flynn KE, Lad T, Lai JS, Reeve BB, Smith AW, Stone AA, Weinfurt K (2007) Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. J Clin Oncol 25:5106-5112
12. Basch E, Artz D, Dulko D, Scher K, Sabbatini P, Hensley M, Mitra N, Speakman J, McCabe M, Schrag D (2005) Patient online selfreporting of toxicity symptoms during chemotherapy. J Clin Oncol 23:3552-3561
13. Freidank A (1999) Schemata zur Prophylaxe von Zytostatikainduzierter Emesis und Nausea. Krankenhauspharmazie 20:49-54
14. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JCJM, Kaasa S, Klee M, Osoba D, Razavi D, Rofe P, Schraub S, Sneeuw K, Sullivan M, Takeda F, for the European Organisation for Research and Treatment of Cancer Study Group on Quality of Life (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376
15. Fayers PM, Aaronson NK, Bjordal K, Curran D, Groenvold M (1999) The EORTC QLQ-C30 scoring manual. European Organization for Research and Treatment of Cancer, Brussels
16. Liekweg A, Eckhardt M, Taylor SC, Erdfelder E, Jaehde U (2005) Psychometric assessment and application of a questionnaire measuring patient: satisfaction with information on cancer treatment. Pharm World Sci 27:96-103
17. Brunner E, Domhof S, Langer F (2001) Nonparametric analysis of longitudinal data in factorial experiments. Wiley, New York
18. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M (2008) Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 337:a1655
19. Doherty KM (1999) Closing the gap in prophylactic antiemetic therapy: patient factors in calculating the emetogenic potential of chemotherapy. Clin J Oncol Nurs 3:113-119
20. American Society of Clinical Oncology, Kris MG, Hesketh PJ, Somerfield MR, Feyer P, Clark-Snow R, Koeller JM, Morrow GR, Chinnery LW, Chesney MJ, Gralla RJ, Grunberg SM (2006) American Society of Clinical Oncology guideline for antiemetics in oncology: update2006. J Clin Oncol 24:2932-2947
21. Italian Group for Antiemetic Research (1998) Transferability to clinical practice of the results of controlled clinical trials: the case of antiemetic prophylactic treatment for cancer chemotherapyinduced nausea and vomiting. Ann Oncol 9:759-765
22. Kaiser R (2005) Antiemetic guidelines: are they being used? Lancet Oncol 6:622-625
23. Dranitsaris G, Warr D, Puodziunas A (1995) A randomized trial of the effects of pharmacist intervention on the cost of antiemetic therapy with ondansetron. Support Care Cancer 3:183-189
24. Warr DG, Hesketh PJ, Gralla RJ, Muss HB, Herrstedt J, Eisenberg PD, Raftopoulos H, Grunberg SM, Gabriel M, Rodgers A, Bohidar N, Klinger G, Hustad CM, Horgan KJ, Skobieranda F (2005) Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy. J Clin Oncol 23:2822-2830
25. Jahn P, Renz P, Stukenkemper J, Book K, Kuss O, Jordan K, Horn I, Thoke-Colberg A, Schmoll HJ, Landenberger M (2009) Reduction of chemotherapy-induced anorexia, nausea, and emesis through a structured nursing intervention: a cluster-randomized multicenter trial. Support Care Cancer 17:1543-1552
26. Ravens-Sieberer U (2002) Measuring and monitoring quality-oflife in population surveys: still a challenge for public health research. Soz Praventivmed 47:203-204
27. Boehmer S, Luszczynska A (2006) Two kinds of items in quality of life instruments: 'indicator and causal variables' in the EORTC qlq-c30. Qual Life Res 15:131-141
28. Carver CS, Lehman JM, Michael HA (2003) Dispositional pessimism predicts illness-related disruption of social and recreational activities among breast cancer patients. J Pers Soc Psychol 84:813-821
29. Allison PJ, Guichard C, Gilain L (2000) A prospective investigation of dispositional optimism as a predictor of health-related quality of life in head and neck cancer patients. Qual Life Res 9:951-960
30. Brenes GA, Rapp SR, Rejeski WJ,MillerME (2002)Do optimismand pessimism predict physical functioning? J Behav Med 25:219-231
31. Schou I, Ekeberg O, Ruland CM (2005) The mediating role of appraisal and coping in the relationship between optimismpessimism and quality of life. Psychooncology 14:718-727
32. Luker KA, Beaver K, Leinster SJ, Owens RG (1996) Information needs and sources of information for women with breast cancer: a follow-up study. J Adv Nurs 23:487-495
33. Adams M (1991) Information and education across the phases of cancer care. Semin Oncol Nurs 7:105-111
34. Di Blasi Z, Harkness E, Ernst E, Georgiou A, Kleijnen J (2001) Influence of context effects on health outcomes: a systematic review. Lancet 357:757-762
35. Campbell M, Donner A, Klar N (2007) Developments in cluster randomized trials and Statistics in Medicine. Stat Med 26:2-19